Novartis recently announced updated results from its landmark COMBI-AD clinical trial, demonstrating that in patients with high-risk stage III BRAF-mu···【Read More】
Update: 2026-04-02Source: Haiou HealthViews: 86
On June 22, 2017, the U.S. Food and Drug Administration (FDA) approved the combination of dabrafenib and trametinib (DABRAFENIB® and TRAMETINIB®, Nova···【Read More】
Update: 2026-04-02Source: Haiou HealthViews: 86
The U.S. Food and Drug Administration (FDA) has approved dabrafenib (TAFINLAR®, Novartis Pharmaceuticals Corp.) and trametinib (MEKINIST®, Novartis Ph···【Read More】
Update: 2026-04-02Source: Haiou HealthViews: 84
According to the American Cancer Society, breast cancer is the most common cancer among women in the United States. HR-positive breast cancer (express···【Read More】
Update: 2026-04-02Source: Haiou HealthViews: 81
AstraZeneca recently announced positive results from the Phase 3 CAPItello-281 clinical trial. The analysis showed that in patients with PTEN-deficien···【Read More】
Update: 2026-04-02Source: Haiou HealthViews: 80
AstraZeneca recently announced positive top-line results from the Phase 3 CAPItello-291 trial. This global, double-blind, randomized Phase 3 study for···【Read More】
Update: 2026-04-02Source: Haiou HealthViews: 82
Belzutifan may be affected by other medications, including prescription drugs, over-the-counter products, vitamins, and herbal supplements. Inform you···【Read More】
Update: 2026-04-02Source: Haiou HealthViews: 88
Adhere to your healthcare provider’s guidance regarding any limitations on food, drink, or daily activities.【Read More】
Update: 2026-04-02Source: Haiou HealthViews: 88
Seek immediate emergency medical assistance or contact the Poison Control Helpline.【Read More】
Update: 2026-04-02Source: Haiou HealthViews: 88
Take the missed dose as soon as you remember on the same day. Continue with your next dose at the usual scheduled time and maintain your once-daily do···【Read More】
Update: 2026-04-02Source: Haiou HealthViews: 89
Belzutifan has shown objective response in the treatment of adult patients with VHL-related tumors, certain advanced RCC, and PPGL aged 12 years and o···【Read More】
Update: 2026-04-01Source: Haiou HealthViews: 100
Because Belzutifan's mechanism of action involves regulating oxygen-sensing pathways in the tumor microenvironment, it may have a wide-ranging imp···【Read More】
Update: 2026-04-01Source: Haiou HealthViews: 103
Belzutifan, a novel anti-tumor drug targeting HIF-2α, requires strict adherence to individualized treatment principles to control disease progression ···【Read More】
Update: 2026-04-01Source: Haiou HealthViews: 102
Belzutifan is a targeted therapy drug used to treat specific cancers, and its price varies significantly depending on factors such as region, dosage, ···【Read More】
Update: 2026-04-01Source: Haiou HealthViews: 94
On May 14, 2025, Merck announced that the U.S. Food and Drug Administration (FDA) has approved Welireg (belzutifan) for the treatment of adult and ped···【Read More】
Update: 2026-04-01Source: Haiou HealthViews: 96
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos



